MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

The role of phosphodiesterase 4 in sleep disturbances in Parkinson’s disease

H. Wilson, G. Pagano, F. Niccolini, N. Muhlert, C. Coello, M. Mehta, G. Searle, R. Gunn, E. Rabiner, T. Foltynie, M. Politis (London, United Kingdom)

Meeting: 2017 International Congress

Abstract Number: 1540

Keywords: Excessive daytime sleepiness(EDS), Parkinsonism, Positron emission tomography(PET)

Session Information

Date: Thursday, June 8, 2017

Session Title: Parkinson's Disease: Neuroimaging And Neurophysiology

Session Time: 1:15pm-2:45pm

Location: Exhibit Hall C

Objective: We aimed to assess the association between phosphodiesterase 4 (PDE4) expression and sleep disturbances in vivo using combined multimodal magnetic resonance imaging (MRI) and PET molecular imaging with [11C]rolipram in Parkinson’s disease (PD).

Background: Sleep disturbances are very common in patients with PD. Animal and genome-wide association studies have suggested a link between cAMP/PKA signalling, PDE4 expression (an enzyme which hydrolyses cAMP) and daytime sleepiness.

Methods: 12 PD patients and 5 healthy controls underwent clinical and imaging assessments. Sleep disturbances were assessed with the Parkinson’s disease sleep scale (PDSS), Epworth Sleepiness Scale (ESS) a measure of excessive daytime sleepiness (EDS), UPDRS-I single items for sleep and fatigue, and non-motor symptom scale (NMSS) domain 2 sleep/fatigue. MIAKATTM was used to generate parametric images of [11C]rolipram volume of distribution (VT) with the Logan plot. FMRIB’s diffusion toolbox (FDT) was used to perform probabilistic tractography on each subjects’ diffusion data to functionally parcellate the striatum according to cortico-striatal projections to generate connectivity maps for limbic, cognitive and sensorimotor subdivisions of the striatum.

Results: PD patients with EDS had significantly increased VT values compared to those without EDS. Higher ESS scores, indicating greater EDS, correlated with higher PDE4 VT in cortical regions involved in the limbic loop [amygdala (r=0.670), hippocampus (r=0.813), orbitofrontal (r=0.685), cingulate (r=0.663) and temporal cortex (r=0.809)], striatum (0.713), thalamus (r=0.660), hypothalamus (r=0.819) and accumbens (r=0.738). Furthermore, higher EDS was associated with specific increases in PDE4 within limbic portions of the striatum (connectivity based analysis, (r=0.788).

Conclusions: Our findings indicate converging evidence for an association between daytime sleepiness and elevated PDE4 in cortical and subcortical limbic regions, implicating PDE4 in the pathophysiology of sleep disturbances in PD. 

To cite this abstract in AMA style:

H. Wilson, G. Pagano, F. Niccolini, N. Muhlert, C. Coello, M. Mehta, G. Searle, R. Gunn, E. Rabiner, T. Foltynie, M. Politis. The role of phosphodiesterase 4 in sleep disturbances in Parkinson’s disease [abstract]. Mov Disord. 2017; 32 (suppl 2). https://www.mdsabstracts.org/abstract/the-role-of-phosphodiesterase-4-in-sleep-disturbances-in-parkinsons-disease/. Accessed June 14, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/the-role-of-phosphodiesterase-4-in-sleep-disturbances-in-parkinsons-disease/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Humor processing is affected by Parkinson’s disease and levodopa
      • Help & Support
      • About Us
      • Cookies & Privacy
      • Wiley Job Network
      • Terms & Conditions
      • Advertisers & Agents
      Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
      Wiley